Major trends in and development prospects for the Russian market of injectable neuroprotectors

Introduction. The positive effects of neuroprotectors are due to their widespread use to rehabilitate patients after stroke, head injuries, and prior neurological diseases. Neuroprotective drugs are most frequently used as injections. There is no publicly available marketing research on this pharmaceutical market segment. Objective: to analyze sales and price levels and pricing trends on the Russian market of injectable neuroprotectors, to identify major trends in the growth of this pharmaceutical market segment, and to assess prospects for its development. Material and methods. The research was based on data from the retail and hospital audits of drug sales in Russia, which were provided by IMS Health and Quintiles (IQVIA). Results. Based on the data of the retail and hospital audits of drug sales, the investigators calculated the volumes of sales of injectable formulations of neuroprotectors in monetary and physical terms. They studied the time course of changes in sales volumes, drug price levels, and drug pricing trends and the analysis of import substitution. Conclusion. The research has shown the prospects of the Russian market of injectable neuroprotectors due to the growth of drug sales and to the increase in the share of Russian medicines.